http://rdf.ncbi.nlm.nih.gov/pubchem/patent/GB-919830-A

Outgoing Links

Predicate Object
assignee http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_fb3edb9a697ebfa78026d99c5a81b3c3
classificationCPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07J75-00
classificationIPCInventive http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J75-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07J5-00
filingDate 1959-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
inventor http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_d2e6c536f22f2d0e461c216eb99c5bd6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_58e652020c18043b9cc18265d457d5a4
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_f2550a3518075dba27d5cf64671cd4b8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_7e26c048343e6bb5a2cdbcd2f0a911ce
publicationDate 1963-02-27-04:00^^<http://www.w3.org/2001/XMLSchema#date>
publicationNumber GB-919830-A
titleOfInvention Esters of cortical steroid hormones
abstract The invention comprises esters of 17a -hydroxy- and 17a ,21-dihydroxy-3,20-diketo-4-pregnenes and the corresponding 1,4-pregnadienes with b -(p-alkoxyphenyl)-propionic acids of the general formula <FORM:0919830/IV (b)/1> wherein R represents an alkyl group containing 1 to 12 carbon atoms, and the preparation thereof by reacting the required steroid with the anhydride or the acid chloride of an acid of the above formula in a solvent such as pyridine, benzene, toluene, ether or chloroform at a temperature between 0 DEG C. and the boiling point of the reaction mixture, for a period between half an hour and 72 hours. When an acid anhydride is used as the esterifying agent, the reaction may be carried out in the presence of an acid catalyst such as p-toluenesulphonic acid. Thus the product may be a 17-ester of 17a -hydroxyprogesterone or a 21-ester of 11-desoxycorticosterone, cortisone, hydrocortisone, prednisone or prednisolone. Therapeutic compositions having hormonal activity suitable for injection contain as the active ingredient the esters defined above, e.g. dissolved in sesame or peanut oil.
isCitedBy http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-4001219-A
priorityDate 1959-07-16-04:00^^<http://www.w3.org/2001/XMLSchema#date>
type http://data.epo.org/linked-data/def/patent/Publication

Incoming Links

Predicate Subject
isDiscussedBy http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6166
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5754
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419558313
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID241
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559261
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419506586
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559517
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID3283
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5755
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419553814
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6101
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6212
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456922693
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419533988
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID456171974
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1140
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID312
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419477255
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID22796701
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID1049
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419547992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419527393
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419485992
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419502355
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID6238
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID419559219
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID222786
http://rdf.ncbi.nlm.nih.gov/pubchem/substance/SID420033637
http://rdf.ncbi.nlm.nih.gov/pubchem/compound/CID5865

Total number of triples: 46.